Table 2.
Summary of patient characteristics.
| Patient characteristics (N = 13 patients) | |
|---|---|
| Age, years | |
| Median | 71 |
| Range | 42–83 |
| Sex | |
| Male | 5 |
| Female | 8 |
| Disease Type | |
| De Novo | 3 |
| Secondary AML | 1 |
| Relapsed | 6 |
| Primary Refractory | 2 |
| Relapsed Refractory | 1 |
| ELN category | |
| Favorable | 1 |
| Intermediate-I | 5 |
| Intermediate-II | 1 |
| Adverse | 6 |
| Number of prior therapies | |
| < 2 | 4 |
| ≥ 2 | 6 |
| Prior allogeneic SCT | 4 |
13 patients were treated at 3 dose levels. ELN refers to European LeukemiaNet; AML refers to acute myeloid leukemia; SCT refers to stem cell transplant.